MoneyWorks4Me

Beryl Drugs informs about outcome of EGM

11 May 2026 Evaluate
Beryl Drugs has informed that member of Beryl Drugs in its duly called and convened Extra-Ordinary General Meeting held on Monday, the 11th day of May, 2026 at 11:00 AM and concluded at 11:30 AM at Kanchan Palace, Community Hall, Nipania Ring Road, Indore- 452001 transacted the following business with requisite majority; Considered and approved the appointment of Shailendra Pathak (DIN: 11169772), as a whole-time director of the company; Considered and approved the appointment of Neha Sarda (DIN: 08456141) as a non-executive independent director of the company; Considered and approved the material related party transactions with Aminova infusions. The Extra-Ordinary General Meeting of the Company commenced at 11:00 AM and concluded at 11:30 AM.

The above information is a part of company’s filings submitted to BSE.

Beryl Drugs Share Price

24.04 1.75 (7.85%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: